Hyperfine, Inc.

WHO'M
ai
Digital Profiler. Einfach den AI-Button klicken
CUSIP
44916K106
SEDOL
BP6W0G0
CIK
0001833769
hyperfine.io
LEI:
©
New: Infographics X-Lab
FIGI: BBG00YVTN9J2
HYPR
Hyperfine, Inc.
GICS: - · Sektor: Healthcare · Sub-Sektor: Medical Devices
AI
PROFILER
NAME
Hyperfine, Inc.
ISIN
US44916K1060
TICKER
HYPR
MIC
XNAS
REUTERS
HYPR.OQ
BLOOMBERG
HYPR US
F&G: 35
5.523,04 S&P · 0,00 Vola-Index · 94.199,50 BTC · 0,00000 EURUSD
BUILD THEMEFOLIO IDEEN TEILEN DISKUTIEREN
HEBEL INVESTIEREN
Financial Intelligence
360° iHub Crowd ATH Tracker Index Tracker ETF TF Spicy X-Billboard
FÜR INVESTOREN
FÜR TRADER
Börsenhandel Warrants
Der X-News Explorer ist die ultimative Informationsquelle für börsenaffine Anleger, die sich schnell und komfortabel einen Überblick über die aktuelle Nachrichtenlage eines börsennotierten Unternehmens verschaffen möchten. Ihnen stehen hier verschiedene Newswire-Services zur Verfügung. Wird ein News-Alert angezeigt, liegen Unternehmensnachrichten vor, die Sie möglicherweise interessieren könnten. Dieser Service wird Ihnen von BusinessWire bereitgestellt.
Di., 15.04.2025       Hyperfine
US44916K1060

Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable magnetic resonance (MR) brain imaging system—the Swoop® system, first approved in 2021—today announced the enrollment of initial patients in the NEURO PMR (Neurological Evaluation in the Offic...
weiterlesen
Hyperfine
Research & Analysen Termsheet Terminal
Permalink
Mo., 17.03.2025       Hyperfine
US44916K1060

Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable magnetic resonance (MR) brain imaging system—the Swoop® system—today announced a strategic collaboration with NVIDIA. This collaboration leverages NVIDIA AI expertise and accelerated computing...
weiterlesen
Hyperfine
Research & Analysen Termsheet Terminal
Permalink
Di., 04.03.2025       Hyperfine
US44916K1060

Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable magnetic resonance (MR) brain imaging system—the Swoop® system—today announced that it will report financial results for the fourth quarter and full year 2024 on Monday, March 17, 2025. Management will h...
weiterlesen
Hyperfine
Research & Analysen Termsheet Terminal
Permalink
Di., 11.02.2025       Hyperfine
US44916K1060

Hyperfine, Inc. (Nasdaq: HYPR) (“Hyperfine” or the “Company”) today announced it has entered into a definitive agreement with investors for the purchase and sale of 4,511,278 shares of the Company’s Class A common stock and warrants to purchase up to 4,511,278 shares of Class A common stock. Each share of Class A common stock and accompanying warr...
weiterlesen
Hyperfine
Research & Analysen Termsheet Terminal
Permalink
Do., 06.02.2025       Hyperfine
US44916K1060

Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the world’s first FDA-cleared AI-powered portable magnetic resonance (MR) brain imaging system—the Swoop® system—today announced the presentation of two studies at the 2025 International Stroke Conference (ISC), which provide evidence...
weiterlesen
Hyperfine
Research & Analysen Termsheet Terminal
Permalink
Di., 17.12.2024       Hyperfine
US44916K1060

Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable magnetic resonance (MR) brain imaging system—the Swoop® system—today announced further global expansion of its commercial operations through agreements with experienced distributors to support...
weiterlesen
Hyperfine
Research & Analysen Termsheet Terminal
Permalink
Do., 05.12.2024       Hyperfine
US44916K1060

Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable magnetic resonance (MR) brain imaging system—the Swoop® system—today highlighted data and conclusions presented at the Radiological Society of North America (RSNA) 2024 Annual Meeting in Chica...
weiterlesen
Hyperfine
Research & Analysen Termsheet Terminal
Permalink
Di., 03.12.2024       Hyperfine
US44916K1060

Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable magnetic resonance (MR) brain imaging system—the Swoop® system—today announced the appointment of Chi Nguyen as Vice President of Office Strategy and Partnerships and Rafael Donnay as Vice Pre...
weiterlesen
Hyperfine
Research & Analysen Termsheet Terminal
Permalink
Do., 21.11.2024       Hyperfine
US44916K1060

Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable magnetic resonance (MR) brain imaging system—the Swoop® system—today announced the issuance of new MRI standards by the Intersocietal Accreditation Commission (IAC), a leading CMS-approved accrediting bo...
weiterlesen
Hyperfine
Research & Analysen Termsheet Terminal
Permalink
Di., 19.11.2024       Hyperfine
US44916K1060

Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable magnetic resonance (MR) brain imaging system—the Swoop® system—today announced that ten scientific abstracts highlighting ultra-low-field imaging will be presented at the Radiological Society of North Am...
weiterlesen
Hyperfine
Research & Analysen Termsheet Terminal
Permalink
We are different
OPEN FINANCIAL
DATA & KNOWLEDGE HUB
We make the difference
Informationen zu Product Placements

 

SMART * AD
EN GIF 970X250

P R O D U C T   S U G G E S T I O N S